ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,677Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 625

$783K Total Retail Price of All Prescriptions

Rank: 64 out of 625

562 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 562 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 562 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 10,042 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
OMEPRAZOLE 414 339 1 6
HYDROCODONE-ACETAMINOPHEN 400 271 S3 2 4
LEVOTHYROXINE SODIUM 384 310 3 3
LISINOPRIL 354 279 4 5
PRAVASTATIN SODIUM 348 305 5 8
ZOLPIDEM TARTRATE 335 231 6 13
SIMVASTATIN 332 281 7 2
AMLODIPINE BESYLATE 317 265 8 1
TRAMADOL HCL 283 259 9 16
FUROSEMIDE 239 191 10 7
RANITIDINE HCL 222 170 11 25
GABAPENTIN 221 156 12 14
SYNTHROID 220 178 13 39
METFORMIN HCL 202 156 14 10
FLUOXETINE HCL 201 150 15 62
METOPROLOL SUCCINATE 192 151 16 15
SERTRALINE HCL 187 153 17 26
HYDROCHLOROTHIAZIDE 181 146 18 12
ATORVASTATIN CALCIUM 152 114 19 9
NEXIUM 152 99 19 21
METOPROLOL TARTRATE 149 111 21 11
POTASSIUM CHLORIDE 143 125 22 19
LOSARTAN POTASSIUM 134 128 23 18
AZITHROMYCIN 129 93 24 40
CARVEDILOL 121 104 25 23
GLIPIZIDE ER 113 103 26 68
METFORMIN HCL ER 109 84 27 41
TAMSULOSIN HCL 108 105 28 36
BENAZEPRIL HCL 102 98 29 35
ROPINIROLE HCL 101 74 30 96
ATENOLOL 101 94 30 22
CLOPIDOGREL 94 82 32 30
PREDNISONE 91 34 33 37
DIOVAN 91 78 33 28
PLAVIX 90 81 35 43
CIPROFLOXACIN HCL 88 75 36 60
LISINOPRIL-HYDROCHLOROTHIAZIDE 88 76 36 27
GLIPIZIDE 86 76 38 56
MIRTAZAPINE 85 62 39 69
GLIPIZIDE XL 79 75 40 83
TRAZODONE HCL 78 53 41 51
CYCLOBENZAPRINE HCL 78 46 R 41 65
ESCITALOPRAM OXALATE 73 58 43 67
NAMENDA 64 64 44 45
KLOR-CON M20 64 59 44 47
FENOFIBRATE 64 50 44 59
MELOXICAM 62 52 47 31
INSULIN SYRINGE 62 41 47 77
LANTUS 60 32 49 54
CYMBALTA 59 30 50 46
CITALOPRAM HBR 59 46 50 24
ADVAIR DISKUS 56 54 52 63
LOVASTATIN 55 44 53 58
COLESTIPOL HCL 54 47 54 226
RAMIPRIL 54 48 54 78
GEMFIBROZIL 53 42 56 127
PROAIR HFA 53 44 56 57
VENLAFAXINE HCL ER 53 35 56 86
ISOSORBIDE MONONITRATE ER 53 47 56 49
SPIRIVA 53 50 56 70
DIGOXIN 51 37 61 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.